Results 131 to 140 of about 251,175 (335)

Continuous follicle-stimulating hormone exposure from pituitary adenoma causes periodic follicle recruitment and atresia, which mimics ovarian hyperstimulation syndrome

open access: yesInternational Journal of Women's Health, 2012
Mika Kanaya,1 Tsuyoshi Baba,2 Yoshimitsu Kitajima,2 Keiko Ikeda,2 Ayumi Shimizu,2 Miyuki Morishita,2 Hiroyuki Honnma,3 Toshiaki Endo,2 Tsuyoshi Saito21Mika Ladies Clinic, 2Department of Obstetrics and Gynecology, Sapporo Medical University, School of ...
Morishita M   +8 more
doaj  

Pediatric Thyroid Cancer Multidisciplinary Team Improves Adherence of Radioactive Iodine Treatment According to National Guidelines

open access: yesOtolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective To evaluate whether a multidisciplinary team (MDT) approach improves adherence to the 2015 American Thyroid Association (ATA) postoperative surveillance guidelines in pediatric thyroid cancer patients. Methods A retrospective review at our institution was performed on pediatric patients who had thyroidectomy for papillary or ...
Shravan Gowrishankar   +7 more
wiley   +1 more source

Revisionist history uncovers a simplified molecular‐based classification of differentiated thyroid cancer

open access: yesThe Journal of Pathology, EarlyView.
Abstract The diagnostic classification of differentiated thyroid cancer has been a longstanding topic of debate among pathologists, largely due to high interobserver variability. This complexity has increased with the expansion of tumor types and subtypes.
Sylvia L Asa   +8 more
wiley   +1 more source

Reproductive adverse events in patients with non‐Hodgkin lymphoma treated with chemotherapeutic regimens including cyclophosphamide, doxorubicin, vincristine, prednisone or CHOP with rituximab: A systematic review and meta‐analysis

open access: yesPediatric Discovery, EarlyView.
The regimen of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R‐CHOP) is the first‐line treatment for non‐Hodgkin lymphoma (NHL). Nine articles involving 331 patients were included in the meta‐analysis, the pooled proportion of reproductive adverse events was 22.3% (95% CI 11.4%–33.2%; p < 0.001). The findings
Rong Han   +6 more
wiley   +1 more source

Phytoestrogen Signal Pathways and Estrogen Signaling in Ovarian Cancer: A Narrative Review

open access: yesPhytotherapy Research, EarlyView.
Phytoestrogen signal pathways targeted in ovarian cancer. ABSTRACT Ovarian cancer (OC) is the second most common gynecological cancer and the leading cause of death from gynecological malignancies. Ovarian cancer mortality rate ranks fifth among cancer‐related deaths in Western societies.
Ozgur Kutuk, Ayse Kaplan
wiley   +1 more source

Follicle-Stimulating Hormone-Producing Pituitary Adenoma: A Case Report and Review of the Literature

open access: yesAACE Clinical Case Reports, 2019
: Objective: To describe an unusual presentation of a follicle-stimulating hormone-secreting pituitary adenoma leading to ovarian hyperstimulation syndrome.
Sonal Patel, BS   +4 more
doaj  

The use of follicle stimulating hormone (FSH) for the treatment of the infertile man: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS)

open access: yesJournal of Endocrinological Investigation, 2018
A. Barbonetti   +12 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy